Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
05/04/201213h10Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201213h00Business WireSpectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/03/201210h14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/201212h03Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/03/201211h00ZacksAllos Upped to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/03/201222h14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/03/201209h15ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/03/201222h00Business WireAllos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/03/201200h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/201223h48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/02/201200h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/201214h00Business WireAllos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201221h33Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201216h43Edgar (US Regulatory)Schedule 13GNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/02/201216h59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/02/201218h46ZacksALTH Seeks Review of Folotyn Verdict - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h30Business WireAllos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines AgencyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h00Business WireAllos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/01/201213h00ZacksEuropean Setback for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201213h43Business WireAllos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/01/201218h15ZacksAllos Therapeutics Cut to Neutral - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/01/201214h15ZacksAMAG Q4 Sales Set to Disappoint - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/01/201214h00Business WireAllos Therapeutics Reports 2011 Financial Highlights and Key Business PrioritiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/12/201114h00Business WireAllos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201116h00ZacksAMAG's Feraheme Gets Canada Nod - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/11/201113h15ZacksAllos Continues to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/11/201114h00ZacksAMAG Hires Financial Advisor - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201110h15ZacksLoss Shrinks at AMAG, CEO Departs - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/201110h05ZacksCompany News for November 4, 2011 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/201112h07Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

Delayed Upgrade Clock